PROMIS measures can be used to assess symptoms and function in long‐term hematopoietic cell transplantation survivors

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|124|4|841-849

ISSN： 0008-543x

Source： CANCER, Vol.124, Iss.4, 2018-02, pp. : 841-849

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Resilience, health, and quality of life among long‐term survivors of hematopoietic cell transplantation

By  

CANCER, Vol. 121, Iss. 23, 2015-12 ,pp. : 4250-4257

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term outcomes among 2‐year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b‐cell lymphoma

By  

CANCER, Vol. 124, Iss. 4, 2018-02 ,pp. : 816-825

John Wiley & Sons Inc

Access to resources Recommend Favorite

Small airways dysfunction in long‐term survivors of pediatric stem cell transplantation

By  

PEDIATRIC PULMONOLOGY, Vol. 50, Iss. 7, 2015-07 ,pp. : 704-712

John Wiley & Sons Inc

Access to resources Recommend Favorite

Erythropoietin therapy after allogeneic hematopoietic cell transplantation has no impact on long‐term survival

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 9, 2015-09 ,pp. : E197-E199

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term safety follow‐up of a randomized trial of darbepoetin alpha and intravenous iron following autologous hematopoietic cell transplantation

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 7, 2015-07 ,pp. : E133-E134

John Wiley & Sons Inc

Access to resources Recommend Favorite